Last updated: August 13, 2023
Sponsor: Jianfeng Yang
Overall Status: Active - Recruiting
Phase
N/A
Condition
Gall Bladder Disorders
Treatment
ELPBD+ESD
EPLBD
Clinical Study ID
NCT05056506
2021-02-01
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- large bile duct stones (≥10 mm)
Exclusion
Exclusion Criteria:
- pregnancy
- refusal of written informed consent
- Patients with benign or malignant biliary stricture
- Contraindications to ERCP exist
- Complicated with acute pancreatitis or acute cholangitis
- Coagulation dysfunction,thrombocytopenia
- prior EST or EPBD
- Patients after gastrointestinal reconstruction
Study Design
Total Participants: 168
Treatment Group(s): 2
Primary Treatment: ELPBD+ESD
Phase:
Study Start date:
September 01, 2021
Estimated Completion Date:
October 30, 2023
Study Description
Connect with a study center
Shanghai Fourth People's Hospital
Shanghai, Shanghai
ChinaActive - Recruiting
Hangzhou First People's Hospital
Hangzhou, Zhejiang 31006
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.